Share

Hello, dear friends! So far we have raised over 13,000 dollars for the CellAge campaign! There are 22 days left before the campaign ends, and it is time to make another push towards the victory line. Also we have an exciting announcement: the CellAge project is now endorsed by LongeCity, one of the oldest international pro-longevity organizations.

Their forum represents an exclusive education platform that has helped thousands of people learn about the endeavor to bring aging processes under medical control, remain informed about the latest breakthroughs, and develop their own strategy of health maintenance.

The LongeCity community has certified this important research project to target and remove harmful senescent cells, and is contributing $800 right away. They are also running an internal fund match: anything donated via this special page on LongeCity before February, 18 will be doubled up to $3000, and then the whole amount will be sent to support the CellAge campaign on Lifespan.io.

Donations made this way will still be eligible for corresponding Lifespan.io rewards, so don’t hold back! You are very welcome to contribute, and please remember that every dollar you donate on the LongeCity page becomes two – and the project will receive a nice push to get us to our goal: control over senescent cells!

CategoryBlog
About the author

Steve Hill

As a scientific writer and a devoted advocate of healthy longevity technologies Steve has provided the community with multiple educational articles, interviews and podcasts, helping the general public to better understand aging and the means to modify its dynamics. His materials can be found at H+ Magazine, Longevity reporter, Psychology Today and Singularity Weblog. He is a co-author of the book “Aging Prevention for All” – a guide for the general public exploring evidence-based means to extend healthy life (in press).

Write a comment:

*

Your email address will not be published.

two × three =

© 2017 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

       Powered by MMD